166 related articles for article (PubMed ID: 12682291)
1. A silent bomb: the risk of anthrax as a weapon of mass destruction.
Webb GF
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4355-6. PubMed ID: 12682291
[No Abstract] [Full Text] [Related]
2. Bioterrorism threat becomes reality.
Ready T
Nat Med; 2001 Nov; 7(11):1167. PubMed ID: 11689863
[No Abstract] [Full Text] [Related]
3. Learning from the 2001 anthrax attacks: immunological characteristics.
Hadler JL
J Infect Dis; 2007 Jan; 195(2):163-4. PubMed ID: 17191158
[No Abstract] [Full Text] [Related]
4. From the Centers for Disease Control and Prevention. Additional options for preventive treatment for exposed persons to inhalational anthrax.
JAMA; 2002 Feb; 287(5):579. PubMed ID: 11838446
[No Abstract] [Full Text] [Related]
5. Zoonosis update. Anthrax.
Shadomy SV; Smith TL
J Am Vet Med Assoc; 2008 Jul; 233(1):63-72. PubMed ID: 18593313
[No Abstract] [Full Text] [Related]
6. Bioterrorism. This time it was real: knowledge of anthrax put to the test.
Enserink M
Science; 2001 Oct; 294(5542):490-1. PubMed ID: 11641469
[No Abstract] [Full Text] [Related]
7. Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.
Osorio M; Wu Y; Singh S; Merkel TJ; Bhattacharyya S; Blake MS; Kopecko DJ
Infect Immun; 2009 Apr; 77(4):1475-82. PubMed ID: 19179420
[TBL] [Abstract][Full Text] [Related]
8. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.
Doolan DL; Freilich DA; Brice GT; Burgess TH; Berzins MP; Bull RL; Graber NL; Dabbs JL; Shatney LL; Blazes DL; Bebris LM; Malone MF; Eisold JF; Mateczun AJ; Martin GJ
J Infect Dis; 2007 Jan; 195(2):174-84. PubMed ID: 17191162
[TBL] [Abstract][Full Text] [Related]
9. Risk of deliberately induced anthrax outbreak.
Ala'Aldeen D
Lancet; 2001 Oct; 358(9291):1386-8. PubMed ID: 11705480
[No Abstract] [Full Text] [Related]
10. Bioterrorism: an update with a focus on anthrax.
Brachman PS
Am J Epidemiol; 2002 Jun; 155(11):981-7. PubMed ID: 12034576
[No Abstract] [Full Text] [Related]
11. Prophylaxis against anthrax.
Splino M; Patocka J
Acta Medica (Hradec Kralove); 2002; 45(3):85-8. PubMed ID: 12515043
[TBL] [Abstract][Full Text] [Related]
12. Key aspects of the molecular and cellular basis of inhalational anthrax.
Cote CK; Welkos SL; Bozue J
Microbes Infect; 2011 Dec; 13(14-15):1146-55. PubMed ID: 21816231
[TBL] [Abstract][Full Text] [Related]
13. [Anthrax].
Bol P
Ned Tijdschr Tandheelkd; 2003 May; 110(5):198-9. PubMed ID: 12784517
[TBL] [Abstract][Full Text] [Related]
14. Anthrax vaccine and public health policy.
Weiss MM; Weiss PD; Weiss JB
Am J Public Health; 2007 Nov; 97(11):1945-51. PubMed ID: 17901434
[TBL] [Abstract][Full Text] [Related]
15. On the risk of mortality to primates exposed to anthrax spores.
Haas CN
Risk Anal; 2002 Apr; 22(2):189-93. PubMed ID: 12022669
[TBL] [Abstract][Full Text] [Related]
16. [Inhalation anthrax].
Hansen TH
Ugeskr Laeger; 2000 Sep; 162(36):4786-9. PubMed ID: 10994373
[TBL] [Abstract][Full Text] [Related]
17. Anthrax vaccines: present status and future prospects.
Kaur M; Singh S; Bhatnagar R
Expert Rev Vaccines; 2013 Aug; 12(8):955-70. PubMed ID: 23984963
[TBL] [Abstract][Full Text] [Related]
18. [The anthrax bacterium--a biological masterpiece with deadly potential].
Myhre EB
Lakartidningen; 2002 Feb; 99(6):484-7. PubMed ID: 11881219
[No Abstract] [Full Text] [Related]
19. Anthrax: the disease in relation to vaccines.
Hambleton P; Carman JA; Melling J
Vaccine; 1984 Jun; 2(2):125-32. PubMed ID: 6442500
[TBL] [Abstract][Full Text] [Related]
20. Responding to the threat of bioterrorism: a microbial ecology perspective--the case of anthrax.
Atlas RM
Int Microbiol; 2002 Dec; 5(4):161-7. PubMed ID: 12497181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
